Exchange: NASDAQ·Updated 07:45 PM EDT
PODD logo

PODDInsulet Corporation

$159.77
$4.71
(2.86%)
Today
Closed $159.77
$0.23
(0.14%)
After Hours
EarningsAug 5
Mkt Cap$11.39B
Vol1.37M
News
all
press releases
INVESTOR ALERT: Securities Class Action Filed Against Insulet Corporation Investors Encouraged to Contact Kirby McInerney LLP
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Insulet Corporation (Insulet or the Company) (NASDAQ:PODD) securities during the period of February 21, 2025 through May 26, 2026, inclusive (the Class Period).If you...
Business Wire
News Placeholder
More News
News Placeholder
PODD DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Insulet Investors of Securities Class Action Lawsuit Deadline on August 31, 2026
PODD DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Insulet Investors of Securities Class Action Lawsuit Deadline on August 31, 2026 PODD DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Insulet Investors of Securities Class Action Lawsuit Deadline on August 31, 2026 PR Newswire NEW YORK, July 6, 2026...
PR Newswire
News Placeholder
Insulet Now #472 Largest Company, Surpassing Fox
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Insulet Corp (Symbol: PODD) has taken over the #472 spot from Fox Corp (Symbol: FOXA), according to The Online Investor. Market capitalization is an important data po...
Nasdaq News: Markets
News Placeholder
FDA Classifies Insulet Omnipod Recall as Serious After Injury Reports
FDA classified Insulet's Omnipod pod recall as Class I after reports of insulin under-delivery linked to 24 serious injuries.read more...
Benzinga
News Placeholder
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Insulet Corporation (PODD) Shareholders To Inquire About Securities Fraud Class Action
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Insulet Corporation (Insulet or the Company) (NASDAQ: PODD) securities between February...
Business Wire
News Placeholder
Law Offices of Frank R. Cruz Encourages Insulet Corporation (PODD) Shareholders To Inquire About Securities Fraud Class Action
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Insulet Corporation (Insulet or the Company) (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026, inclusive (the Class Period...
Business Wire
News Placeholder
Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harm Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harm PR Newswire NEW YORK, July 6, 2026 NEW YORK, July 6, 2026...
PR Newswire
News Placeholder
Insulet Launches Omnipod 5 Automated Insulin Delivery System In Spain
(RTTNews) - Insulet Corporation (PODD) on Monday said it has launched its Omnipod 5 Automated Insulin Delivery System and Omnipod Discover data management platform in Spain...
Nasdaq News: Markets
News Placeholder
Insulet Accelerates Global Growth with Launch of Omnipod 5 and Omnipod Discover in Spain, Expanding Access to Tubeless Diabetes Technology
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced the commercial launch of its Omnipod 5 Automated Insulin Delivery System and its proprietary data management system Omnipod Discover...
Business Wire
News Placeholder
Rosen Law Firm Urges Insulet Corporation (NASDAQ: PODD) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Insulet Corporation (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026, inclusive (the Class Period). Insulet develops, manufactures, and sells insulin...
Business Wire
<
1
2
...
>

Advertisement|Remove ads.